New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2014
08:46 EDTABBV, SHPG, PFE, AZNBofA/Merrill pharmaceutical analysts hold an analyst/industry conference call
Pharmaceutical Analysts Parry, Jain and Bristow, along with Special Situations Analyst Raghunath and Credit Research Analyst Inguva, discuss AbbVie's recent bid for Shire and the key differences between the bid scenario for Shire/AbbVie and Pfizer's recent bid for AstraZeneca on an Analyst/Industry conference call to be held on June 25 at 10 am.
News For ABBV;SHPG;PFE;AZN From The Last 14 Days
Check below for free stories on ABBV;SHPG;PFE;AZN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
July 21, 2014
06:14 EDTSHPGStocks with implied volatility below IV index mean; INTC SHPG
Subscribe for More Information
06:10 EDTABBVStocks with implied volatility movement; ABBV JOY
Subscribe for More Information
July 18, 2014
18:04 EDTABBV, SHPGAbbVie purchase of Shire worth the premium, Barron's reports
Subscribe for More Information
16:47 EDTSHPG, ABBVMarket ends week higher as earnings, M&A offset geopolitical tensions
Subscribe for More Information
13:46 EDTABBVAbbVie price target raised to $85 from $71 at Jefferies
Subscribe for More Information
11:25 EDTSHPGOptions with decreasing implied volatility
Subscribe for More Information
10:38 EDTSHPGShire downgraded to Fair Value from Buy at CRT Capital
Shire (SHPG) is being acquired by AbbVie (ABBV).
10:34 EDTSHPG, ABBVShire downgraded to Neutral from Overweight at Piper Jaffray
Shire (SHPG) is being acquired by AbbVie (ABBV).
10:30 EDTABBV, SHPGAbbVie says can't back out of Shire deal based on tax law change, Bloomberg says
Subscribe for More Information
09:29 EDTSHPG, ABBVAbbVie, Shire says merger should help in enhanced buyback and dividend programs
Subscribe for More Information
06:23 EDTSHPGShire raises FY14 EPS to low-to-mid 30% growth from mid-to-high teens
Raises FY14 product sales guidance to growth in high teens from mid-to-high teens. Shire continues to expect royalties and other revenues to be 10%-15% lower than 2013.
06:19 EDTSHPGShire reports Q2 EPS $2.67, consensus $2.45
Subscribe for More Information
05:17 EDTSHPG, ABBVAbbVie, Shire agree on merger worth GBP32B pounds
The boards of AbbVie (ABBV) and Shire (SHPG) announced that they have reached agreement on the terms of a recommended combination of Shire with AbbVie. Under the terms of the Merger, Shire shareholders will be entitled to receive per share GBP 24.44 in cash and 0.8960 new AbbVie shares. Immediately following the transaction, Shire shareholders are expected to hold new AbbVie Shares representing approximately 25% of the issued share capital of new AbbVie. AbbVie expects the transaction to be accretive to adjusted earnings per share in the first year following completion, growing to above $1.00 per share by 2020, with "material ongoing financial and operating benefits." The AbbVie board also expects the transaction to reduce New AbbVie's effective tax rate to approximately 13% by 2016. The Shire board said it "considers the terms of the Transaction to be fair and reasonable." In order to undertake the transaction, AbbVie has formed a new company, New AbbVie, which is incorporated in Jersey, Shire's current place of incorporation. Following completion of the Transaction, New AbbVie will become the holding company of the Shire Group and the AbbVie Group. It is intended that the New AbbVie Shares will be listed on the New York Stock Exchange.
05:12 EDTABBV, SHPGAbbVie to acquire Shire for 52.48 pounds per share in cash, stock
Subscribe for More Information
July 17, 2014
13:34 EDTSHPGShire reports results from Vyvanse vs. Concerta studies in adolescents with ADHD
Subscribe for More Information
12:56 EDTSHPG, ABBVAbbVie set to announce GBP 31B deal to buy Shire, FT says
Subscribe for More Information
12:54 EDTABBV, SHPGAbbVie set to announce GBP 31B deal to buy Shire, FT says
Subscribe for More Information
11:12 EDTSHPGOptions with decreasing implied volatility
Subscribe for More Information
08:08 EDTPFEBristol-Myers, Pfizer announce enrollment in Phase IV EMANATE trial for Eliquis
Subscribe for More Information
05:53 EDTABBVStocks with implied volatility movement; HLF ABBV
Stocks with implied volatility movement; Herbalife (HLF) 52, AbbVie (ABBV) 30 according to iVolatility.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use